[EN] BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST<br/>[FR] COMPOSÉS DE BENZYLPIPÉRIDINE UTILISÉS COMME ANTAGONISTES DES RÉCEPTEURS À L'ACIDE LYSOPHOSPHATIDIQUE (LPA)
申请人:MERCK PATENT GMBH
公开号:WO2013045028A9
公开(公告)日:2014-12-24
BENZYL PIPERIDINE COMPOUNDS AS LYSOPHOSPHATIDIC ACID (LPA) RECEPTOR ANTAGONIST
申请人:Merck Patent GmbH
公开号:EP2844648B1
公开(公告)日:2016-11-09
US9527850B2
申请人:——
公开号:US9527850B2
公开(公告)日:2016-12-27
Benzyl Piperidine Compounds as Lysophosphatidic Acid (LPA) Receptor Antagonist
申请人:Schiemann Kai
公开号:US20150011557A1
公开(公告)日:2015-01-08
The invention provides novel substituted benzyl piperidine compounds according to Formula (I) as lysophosphatidic acid (LPA) receptor antagonists, their manufacture and use for the treatment of proliferative or inflammatory diseases, such as cancer, fibrosis or arthritis.